What happens in Vegas stays in Vegas. Well, sort of. Titleist reps are handing out prototype Pro V1 and Pro V1x balls in Sin City this week at the PGA Tour’s Shriners Hospitals for Children Open. It’s all part of the company’s systematic approach for using the world’s top players to test and evaluate products before bringing new models to market.
Las Vegas, in fact, played a key role in the development of the initial Pro V1. Back in October 2000, 47 PGA Tour players first teed up prototype balls in the Invensys Classic in Vegas. Since then, momentum on Tour has only grown. The Pro V1 family’s historic run continues today as 60% to 70% of the field in any given PGA Tour event plays either Pro V1 or Pro V1x.
Here’s what you can expect: Titleist will continue to gather insights and data from its “living laboratory” throughout the fall, and, ultimately, will roll out new versions of Pro V1 and Pro V1x early next year.
The company has had a busy week. Last Friday, Acushnet Holdings (the company behind the Titleist brand) offered an IPO on the New York Stock exchange, where it opened at $17 per share under the ticker symbol GOLF.